 So basically all of the drugs that the FDA makes available. So there's about 2000 drugs that have ever been approved for anything and we screen them alone and in combinations. Every time we do a screen we don't screen 2000 to the third permutation. We've generated intelligence so we know now for a specific mutational profile what drug therapies are likely to work and then we start experimenting with combinations. With each patient screen we do we identify many novel drug combinations usually a cancer drug plus one or two non-cancer drugs which makes it treatment overall less toxic and then the combination itself is quite affordable because we're looking at really small molecules and really interesting drugs we get combinations like a mech inhibitor with anti-asomatic or an anti-hypertensive or metformin or you know very unique therapies that somehow we're working to target that patient's unique mutational profile. That is so wild.